The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
Diabetes Control, D. Nathan, S. Genuth, et al.. (1993). The New England journal of medicine. Cited 20,441 times. https://doi.org/10.1056/NEJM199309303291401Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
D. Nathan, P. Cleary, J. Backlund, et al.. (2005). The New England journal of medicine. Cited 4,514 times. https://doi.org/10.1056/NEJMOA052187Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
J. Lachin, S. Genuth, P. Cleary, et al.. (2000). The New England journal of medicine. Cited 1,448 times. https://doi.org/10.1056/NEJM200002103420603Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
D. Nathan, J. Lachin, P. Cleary, et al.. (2003). The New England journal of medicine. Cited 855 times. https://doi.org/10.1056/NEJMOA022314Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
S. Genuth, Janie Lipps, G. Lorenzi, et al.. (2002). JAMA. Cited 836 times. https://doi.org/10.1001/jama.287.19.2563Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
(2003). JAMA. Cited 636 times.Implementation of Treatment Protocols in the Diabetes Control and Complications Trial
H. Shamoon, H. Duffy, N. Fleischer, et al.. (1995). Diabetes Care. Cited 277 times. https://doi.org/10.2337/diacare.18.3.361Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
H. Shamoon, P. Cleary, A. Barnie, et al.. (1999). Diabetes care. Cited 59 times. https://doi.org/10.2337/DIACARE.22.1.99